Skip Navigation

Bristol-Myers Squibb CEO: We are conducting important studies with Nektar

In this video

Bristol-Myers Squibb CEO: We are conducting important studies with Nektar

Giovanni Caforio, Bristol-Myers Squibb chairman and CEO, talks about the company's partnership with Nektar and latest immunotherapy treatments.

03:51

Mon, Jun 4 20188:15 AM EDT

U.S. Trade Representative Katherine Tai on raising China tariffs

U.S. Trade Representative Katherine Tai on raising China tariffs

28 min ago

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

29 min ago

Games Global files to withdraw U.S. IPO plans

Games Global files to withdraw U.S. IPO plans

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Solus' Dan Greenhaus: A positive CPI surprise could push stocks up to record highs

Solus' Dan Greenhaus: A positive CPI surprise could push stocks up to record highs

U.S. Trade Representative Katherine Tai on raising China tariffs

U.S. Trade Representative Katherine Tai on raising China tariffs

28 min ago

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

Former SEC Chair Jay Clayton on meme stocks craze: It bothers me, it is 'certainly not investing'

29 min ago

Games Global files to withdraw U.S. IPO plans

Games Global files to withdraw U.S. IPO plans

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Goldman's Sara Naison-Tarajano: Tremendous amount of growth in the market has come from 'Mag 7'

Solus' Dan Greenhaus: A positive CPI surprise could push stocks up to record highs

Solus' Dan Greenhaus: A positive CPI surprise could push stocks up to record highs